In Veritas Shares Outstanding vs. Market Capitalization

IVME Stock  USD 0.0001  0.00  0.00%   
Based on In Veritas' profitability indicators, In Veritas Medical may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess In Veritas' ability to earn profits and add value for shareholders. At present, In Veritas' Days Of Sales Outstanding is projected to decrease significantly based on the last few years of reporting. As of December 11, 2024, Operating Income is expected to decline to about (2.6 M). In addition to that, Net Loss is expected to decline to about (3.5 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin1.11.14
Sufficiently Down
Slightly volatile
Operating Profit Margin1.710.87
Way Up
Pretty Stable
For In Veritas profitability analysis, we use financial ratios and fundamental drivers that measure the ability of In Veritas to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well In Veritas Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between In Veritas's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of In Veritas Medical over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In Veritas. If investors know IVME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In Veritas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Return On Assets
(6.48)
The market value of In Veritas Medical is measured differently than its book value, which is the value of IVME that is recorded on the company's balance sheet. Investors also form their own opinion of In Veritas' value that differs from its market value or its book value, called intrinsic value, which is In Veritas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In Veritas' market value can be influenced by many factors that don't directly affect In Veritas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In Veritas' value and its price as these two are different measures arrived at by different means. Investors typically determine if In Veritas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In Veritas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

In Veritas Medical Market Capitalization vs. Shares Outstanding Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining In Veritas's current stock value. Our valuation model uses many indicators to compare In Veritas value to that of its competitors to determine the firm's financial worth.
In Veritas Medical is currently regarded as number one stock in shares outstanding category among its peers. It also is currently regarded as number one stock in market capitalization category among its peers . The ratio of Shares Outstanding to Market Capitalization for In Veritas Medical is about  10,000 . At present, In Veritas' Market Cap is projected to decrease significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value In Veritas by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

IVME Market Capitalization vs. Shares Outstanding

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

In Veritas

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
86.05 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

In Veritas

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
8.61 K
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

IVME Market Capitalization vs Competition

In Veritas Medical is currently regarded as number one stock in market capitalization category among its peers. Market capitalization of Financials industry is currently estimated at about 17.66 Billion. In Veritas adds roughly 8,605 in market capitalization claiming only tiny portion of equities under Financials industry.
Capitalization  Valuation  Revenue  Total debt  Workforce

In Veritas Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in In Veritas, profitability is also one of the essential criteria for including it into their portfolios because, without profit, In Veritas will eventually generate negative long term returns. The profitability progress is the general direction of In Veritas' change in net profit over the period of time. It can combine multiple indicators of In Veritas, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-2.4 M-2.6 M
Net Loss-3.3 M-3.5 M
Income Before Tax-3.3 M-3.5 M
Total Other Income Expense Net-857.8 K-900.7 K
Net Loss-3.3 M-3.5 M
Net Loss-3.3 M-3.5 M
Change To Netincome1.4 MM
Income Quality 0.23  0.22 

IVME Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on In Veritas. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of In Veritas position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the In Veritas' important profitability drivers and their relationship over time.

Use In Veritas in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if In Veritas position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In Veritas will appreciate offsetting losses from the drop in the long position's value.

In Veritas Pair Trading

In Veritas Medical Pair Trading Analysis

The ability to find closely correlated positions to In Veritas could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace In Veritas when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back In Veritas - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling In Veritas Medical to buy it.
The correlation of In Veritas is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as In Veritas moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if In Veritas Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for In Veritas can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your In Veritas position

In addition to having In Veritas in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Single Stock ETFs Thematic Idea Now

Single Stock ETFs
Single Stock ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Single Stock ETFs theme has 100 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Single Stock ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether In Veritas Medical is a strong investment it is important to analyze In Veritas' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact In Veritas' future performance. For an informed investment choice regarding IVME Stock, refer to the following important reports:
Check out Risk vs Return Analysis.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
To fully project In Veritas' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of In Veritas Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include In Veritas' income statement, its balance sheet, and the statement of cash flows.
Potential In Veritas investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although In Veritas investors may work on each financial statement separately, they are all related. The changes in In Veritas's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on In Veritas's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.